HRT Financial’s GoodRx Holdings GDRX Stock Holding History

HRT Financial’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,000	Closed	-$246K	–	3495
2021 Q3	$246K	Sell	6,000 -2,100	-26%	-$76.2K	﹤0.01%	2545
2021 Q2	$291K	Buy	+8,100	New	+$299K	﹤0.01%	2156

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial's GDRX Position: Q4 2023 in Review

HRT Financial sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 97,638 shares — an estimated $549K sold.

HRT Financial first reported a position in GDRX in Q2 2022 and held it in 3 quarters. The position peaked at $549K in Q3 2023. 143 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

HRT Financial reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
HRT Financial sold 97,638 GoodRx Holdings shares in Q4 2023, an estimated $549K.
HRT Financial first reported a position in GoodRx Holdings in Q2 2022 and held it in 3 quarters.
HRT Financial's GoodRx Holdings position peaked at $549K in Q3 2023.
143 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.